Early and long-term outcomes of gastric cancer patients treated with perioperative chemotherapy and radical surgery in a single cancer center

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter P. Viapiana
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors P. Viapiana1, W..L. Costa2, S. de Castro Ribeiro Heber2, H. Jesus Victor3, L. Mello Celso2, H. Freitas3, V. Simonetti3, F. Antonio Cury3, A. Godoy3, I. Farias3, L. Diniz Alessandro2, J. Fernandez Coimbra Felipe2
  • 1Universidade Federal do Amazonas, Manaus, Brazil, /
  • 2Hospital A.C. Camargo, Sao Paulo, Brazil, /
  • 3A.C. Camargo Cancer Center, São Paulo, Brazil, /

Abstract

Perioperative chemotherapy has been associated with improved survival in gastric cancer patients treated with curative intent. Evidence is still needed, however, regarding its role in patients treated with D2-lymphadenectomy and the best chemotherapy regimen. The aim of this study is to describe the results of perioperative chemotherapy in patients treated with adequate lymph node dissection in a single cancer center.